Genetic Signature: Microarray-based Gene Expression Profiling to Predict Tumor Sensitivity to Radiotherapy
FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE
Contact
The Innovation Office
813.745.6828
InnovationMarketing@Moffitt.org
14MA052N
